Literature DB >> 141496

Nervous outflow from skeletal muscle following chemical noxious stimulation.

S Mense.   

Abstract

1. In order to determine the nervous outflow from skeletal muscle during chemically induced muscle pain, the impulse activity of various types of muscle afferents in response to close intra-arterial injections of pain-producing substances (bradykinin, 5-hydroxytryptamine, histamine and potassium) was studied in anaesthetized cats using a single fibre recording technique.2. By administration of algesic agents in doses which produce pain in man and pain reactions in animals, about half of the group IV and two thirds of the group III muscle afferents could be activated. In contrast, group II and group I afferent units were usually not excited by chemical noxious stimulation. If effects at all occurred in the thick myelinated afferents, they consisted of a depression of the fibre activity rather than of an activation.3. The qualitative features of the discharges of group III muscle afferents induced by chemical stimulation resembled those of the group IV units very closely. The group III units differed from the group IV afferents in that their responses to a given dose of bradykinin were of greater magnitude.4. It is concluded that the chemically induced muscle pain is probably mediated by certain portions of the group IV and group III afferents, whereas the reactions of group II and group I units to algesic agents are such that a contribution to muscular chemo-nociception seems improbable.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 141496      PMCID: PMC1283603          DOI: 10.1113/jphysiol.1977.sp011802

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  17 in total

1.  Muscle receptors with group IV afferent fibres responding to application of bradykinin.

Authors:  M Franz; S Mense
Journal:  Brain Res       Date:  1975-07-18       Impact factor: 3.252

2.  Bradykinin, digital blood flow, and the arteriovenous anastomoses.

Authors:  G E BURCH; N P DEPASQUALE
Journal:  Circ Res       Date:  1962-01       Impact factor: 17.367

3.  Visceral pain and the pseudaffective response to intra-arterial injection of bradykinin and other algesic agents.

Authors:  F GUZMAN; C BRAUN; R K LIM
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-04-01

4.  Functional analysis of group III afferent fibres of mammalian muscles.

Authors:  A S PAINTAL
Journal:  J Physiol       Date:  1960-07       Impact factor: 5.182

5.  The effect of sympathetic stimulation on mammalian muscle spindles.

Authors:  C C HUNT
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

6.  A comparison of the nerve impulses of mammalian non-medullated nerve fibres with those of the smallest diameter medullated fibres.

Authors:  A S Paintal
Journal:  J Physiol       Date:  1967-12       Impact factor: 5.182

7.  Excitatory effects of 5-hydroxytryptamine, histamine and potassium ions on muscular group IV afferent units: a comparison with bradykinin.

Authors:  S Fock; S Mense
Journal:  Brain Res       Date:  1976-04-09       Impact factor: 3.252

8.  Mechanisms of edema formation by histamine administered locally into canine forelimbs.

Authors:  G J Grega; R L Kline; D E Dobbins; F J Haddy
Journal:  Am J Physiol       Date:  1972-11

9.  Prostaglandins, aspirin-like drugs and analgesia.

Authors:  S H Ferreira
Journal:  Nat New Biol       Date:  1972-12-13

10.  NOCICEPTIVE RESPONSES OF GUINEA-PIGS TO INTRADERMAL INJECTIONS OF BRADYKININ AND KALLIDIN-10.

Authors:  H O COLLIER; I R LEE
Journal:  Br J Pharmacol Chemother       Date:  1963-08
View more
  59 in total

1.  Ischaemia after exercise does not reduce responses of human motoneurones to cortical or corticospinal tract stimulation.

Authors:  J L Taylor; N Petersen; J E Butler; S C Gandevia
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

Review 2.  Neural influences on sprint running: training adaptations and acute responses.

Authors:  A Ross; M Leveritt; S Riek
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Field potentials and excitation of primate spinothalamic neurones in response to volleys in muscle afferents.

Authors:  R D Foreman; D R Kenshalo; R F Schmidt; W D Willis
Journal:  J Physiol       Date:  1979-01       Impact factor: 5.182

4.  Effects of repeated bouts of squatting exercise on sub-maximal endurance running performance.

Authors:  Dean Burt; Kevin Lamb; Ceri Nicholas; Craig Twist
Journal:  Eur J Appl Physiol       Date:  2012-06-10       Impact factor: 3.078

5.  The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat.

Authors:  B D Grubb; G J Birrell; D S McQueen; A Iggo
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

6.  Limitation of physical performance in a muscle fatiguing handgrip exercise is mediated by thalamo-insular activity.

Authors:  Lea Hilty; Lutz Jäncke; Roger Luechinger; Urs Boutellier; Kai Lutz
Journal:  Hum Brain Mapp       Date:  2010-12-10       Impact factor: 5.038

Review 7.  Blood flow restriction training and the exercise pressor reflex: a call for concern.

Authors:  Marty D Spranger; Abhinav C Krishnan; Phillip D Levy; Donal S O'Leary; Scott A Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-04       Impact factor: 4.733

8.  Arterial oxygenation influences central motor output and exercise performance via effects on peripheral locomotor muscle fatigue in humans.

Authors:  Markus Amann; Marlowe W Eldridge; Andrew T Lovering; Michael K Stickland; David F Pegelow; Jerome A Dempsey
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

9.  Identification of a B2 bradykinin receptor expressed by PC12 pheochromocytoma cells.

Authors:  J Nardone; C Gerald; L Rimawi; L Song; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Dependence of histamine-evoked nociception on prostaglandin release.

Authors:  H Juan
Journal:  Agents Actions       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.